Laura Cappelli

Assistant Professor

20062020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2020

Immune checkpoint inhibitor–induced inflammatory arthritis as a model of autoimmune arthritis

Cappelli, L. C., Thomas, M. A., Bingham, C. O., Shah, A. A. & Darrah, E., Mar 1 2020, In : Immunological reviews. 294, 1, p. 106-123 18 p.

Research output: Contribution to journalReview article

The relationships between cancer and autoimmune rheumatic diseases

Cappelli, L. C. & Shah, A. A., Jan 1 2020, (Accepted/In press) In : Best Practice and Research: Clinical Rheumatology. 101472.

Research output: Contribution to journalReview article

2019

2019 American College of Rheumatology Recommended Patient-Reported Functional Status Assessment Measures in Rheumatoid Arthritis

Barber, C. E. H., Zell, J. A., Yazdany, J., Davis, A. M., Cappelli, L., Ehrlich-Jones, L., Everix, D., Thorne, J. C., Bohm, V., Suter, L., Limanni, A. & Michaud, K., Dec 1 2019, In : Arthritis Care and Research. 71, 12, p. 1531-1539 9 p.

Research output: Contribution to journalArticle

Open Access

Addressing immune-related adverse events of cancer immunotherapy: How prepared are rheumatologists?

Kostine, M., Cappelli, L., Calabrese, C., Calabrese, L. H., Bingham, C., Richez, C., Gottenberg, J. E. & Lambotte, O., Jan 1 2019, (Accepted/In press) In : Annals of the Rheumatic Diseases.

Research output: Contribution to journalArticle

Open Access

Association of Baseline Peptidylarginine Deiminase 4 Autoantibodies With Favorable Response to Treatment Escalation in Rheumatoid Arthritis

Darrah, E., Yu, F., Cappelli, L. C., Rosen, A., O'Dell, J. R. & Mikuls, T. R., May 2019, In : Arthritis and Rheumatology. 71, 5, p. 696-702 7 p.

Research output: Contribution to journalArticle

Open Access

Polymyalgia rheumatica-like syndrome from checkpoint inhibitor therapy: Case series and systematic review of the literature

Calabrese, C., Cappelli, L., Kostine, M., Kirchner, E., Braaten, T. & Calabrese, L., Apr 1 2019, In : RMD Open. 5, 1, e000906.

Research output: Contribution to journalArticle

Open Access

Sicca Syndrome Associated with Immune Checkpoint Inhibitor Therapy

Warner, B. M., Baer, A. N., Lipson, E. J., Allen, C., Hinrichs, C., Rajan, A., Pelayo, E., Beach, M., Gulley, J. L., Madan, R. A., Feliciano, J., Grisius, M., Long, L., Powers, A., Kleiner, D. E., Cappelli, L. & Alevizos, I., Sep 1 2019, In : Oncologist. 24, 9, p. 1259-1269 11 p.

Research output: Contribution to journalArticle

Open Access
Open Access
2018

Autoantibodies to peptidylarginine deiminase 2 are associated with less severe disease in rheumatoid arthritis

Darrah, E., Giles, J. T., Davis, R. L., Naik, P., Wang, H., Konig, M. F., Cappelli, L., Bingham, C., Danoff, S. & Andrade, F. A., Nov 20 2018, In : Frontiers in Immunology. 9, NOV, 02696.

Research output: Contribution to journalArticle

Gastrointestinal and Hepatic Disease in Rheumatoid Arthritis

Craig, E. & Cappelli, L., Feb 1 2018, In : Rheumatic Disease Clinics of North America. 44, 1, p. 89-111 23 p.

Research output: Contribution to journalReview article

Rheumatic immune-related adverse events from cancer immunotherapy

Calabrese, L. H., Calabrese, C. & Cappelli, L., Oct 1 2018, In : Nature Reviews Rheumatology. 14, 10, p. 569-579 11 p.

Research output: Contribution to journalReview article

2017

Inflammatory arthritis: A newly recognized adverse event of immune checkpoint blockade

Naidoo, J., Cappelli, L., Forde, P., Marrone, K., Lipson, E., Hammers, H. J., Sharfman, W., Le, D., Baer, A., Shah, A., Albayda, J., Manno, R., Haque, U. J., Gutierrez, A. K., Bingham, C. & Brahmer, J., Jun 1 2017, In : Oncologist. 22, 6, p. 627-630 4 p.

Research output: Contribution to journalComment/debate

Inflammatory arthritis due to immune checkpoint inhibitors: Challenges in diagnosis and treatment

Cappelli, L., Naidoo, J., Bingham, C. & Shah, A., Jan 1 2017, In : Immunotherapy. 9, 1, p. 5-8 4 p.

Research output: Contribution to journalReview article

Tocilizumab treatment leads to improvement in disease activity regardless of CCP status in rheumatoid arthritis

Cappelli, L., Palmer, J. L., Kremer, J. & Bingham, C., 2017, (Accepted/In press) In : Seminars in Arthritis and Rheumatism.

Research output: Contribution to journalArticle

Two Cases of Sinusitis Induced by Immune Checkpoint Inhibition

Dein, E., Sharfman, W., Kim, J., Gellad, F., Shah, A. A., Bingham, C. O. & Cappelli, L. C., Jun 13 2017, (Accepted/In press) In : Journal of Immunotherapy.

Research output: Contribution to journalArticle

2016

Cancer immunotherapy-induced rheumatic diseases emerge as new clinical entities

Cappelli, L., Shah, A. & Bingham, C., 2016, In : RMD Open. 2, 2, e000321.

Research output: Contribution to journalReview article

2015

Management of Raynaud Phenomenon and Digital Ulcers in Scleroderma

Cappelli, L. & Wigley, F. M., Aug 1 2015, In : Rheumatic Disease Clinics of North America. 41, 3, p. 419-438 20 p.

Research output: Contribution to journalReview article

2007

Erratum: An immunoreceptor tyrosine activation motif in the mouse mammary tumor virus envelope protein plays a role in virus-induced mammary tumors (Journal of Virology (2006) 80, 18, (9000-9008))

Ross, S. R., Schmidt, J. W., Katz, E., Cappelli, L., Hultine, S., Gimotty, P. & Monroe, J. G., Nov 1 2007, In : Journal of virology. 81, 22, 1 p.

Research output: Contribution to journalComment/debate

2006

An immunoreceptor tyrosine activation motif in the mouse mammary tumor virus envelope protein plays a role in virus-induced mammary tumors

Ross, S. R., Schmidt, J. W., Katz, E., Cappelli, L., Hultine, S., Gimotty, P. & Monroe, J. G., Sep 1 2006, In : Journal of virology. 80, 18, p. 9000-9008 9 p.

Research output: Contribution to journalArticle